Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas

D. Bradley Welling, Katharine A. Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu, Beth A. Miles-Markley, Craig C. Hofmeister, Mina S. Makary, H. Wayne Slone, Jaishri O. Blakeley, S. Alireza Mansouri, Brian A. Neff, Robert K. Jackler, Amir Mortazavi, Long Sheng Chang

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas'. Together they form a unique fingerprint.

Medicine & Life Sciences